Allergen diagnostics is identifying the allergy and preventing or curing the allergy at the different stages. Allergic diagnosis is segmented based on the different types i.e. from type I to type V. Type I allergy are those which take place primarily on epithelial surfaces which are skin, lungs, gastro intestinal track. Type IV are cellular reactions which involve T lymphocytes. The granulomatous type V allergy can be regarded as a variant of type IV allergy, as it also triggers a cell-mediated immune reaction, but involves macrophages instead of T lymphocytes.
North America dominated the overall industry in terms of revenue in 2014 at over 39.0%. Higher incidence of respiratory allergic disorders, awareness level pertaining to allergy diagnostics and rising adoption of in vitro blood tests are attributing to the largest revenue share of this region. The European market is also expected to show positive growth due to developed pharmaceutical industry and increasing demand for therapeutics. Growing geriatric population and rising incidences of allergic conditions are also contributing to the aforementioned growth.
Asia-Pacific, on the other hand, is expected to be the fastest growing regional industry, by registering CAGR of over 12.0% in coming years due to the presence of high unmet needs, improvising healthcare infrastructure and demand for minimally invasive diagnostic tools from the consumer end.

Market Analysis and Insights: Global Allergy Diagnostics And Therapeutics Market
The global Allergy Diagnostics And Therapeutics market size is projected to reach US$ 35890 million by 2027, from US$ 27990 million in 2020, at a CAGR of 3.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergy Diagnostics And Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergy Diagnostics And Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergy Diagnostics And Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergy Diagnostics And Therapeutics market.

Global Allergy Diagnostics And Therapeutics Scope and Market Size
Allergy Diagnostics And Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergy Diagnostics And Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instruments
Consumables
Services

Segment by Application
Diagnostic Laboratories
Hospitals
Academic Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
bioMerieux
Thermo Fisher Scientific
Danaher Corporation
Omega Diagnostics
Hitachi Chemical Diagnostics
Stallergenes Greer
Siemens Healthcare
Lincoln Diagnostics
Hycor Biomedical
HOB Biotech Group
Alcon Laboratories